| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Osteogenesis | 22 | 2026 | 154 | 5.280 |
Why?
|
| Bone and Bones | 17 | 2026 | 152 | 3.780 |
Why?
|
| Osteoblasts | 27 | 2026 | 204 | 3.640 |
Why?
|
| Osteoclasts | 9 | 2026 | 53 | 3.020 |
Why?
|
| Genetic Therapy | 9 | 2025 | 849 | 2.790 |
Why?
|
| Bone Development | 8 | 2026 | 33 | 2.750 |
Why?
|
| Ubiquitin Thiolesterase | 4 | 2026 | 25 | 2.610 |
Why?
|
| Endosomal Sorting Complexes Required for Transport | 7 | 2026 | 61 | 2.550 |
Why?
|
| Osteoporosis | 6 | 2025 | 113 | 2.540 |
Why?
|
| Ossification, Heterotopic | 4 | 2026 | 14 | 2.510 |
Why?
|
| Bone Resorption | 7 | 2026 | 46 | 2.380 |
Why?
|
| Dependovirus | 7 | 2025 | 758 | 2.260 |
Why?
|
| Bone Diseases | 3 | 2026 | 25 | 1.870 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 4 | 2022 | 80 | 1.820 |
Why?
|
| Myositis Ossificans | 3 | 2023 | 7 | 1.740 |
Why?
|
| Arthritis, Rheumatoid | 3 | 2025 | 346 | 1.680 |
Why?
|
| Endopeptidases | 3 | 2026 | 67 | 1.630 |
Why?
|
| Signal Transduction | 28 | 2026 | 3155 | 1.620 |
Why?
|
| Adaptor Proteins, Signal Transducing | 14 | 2024 | 441 | 1.590 |
Why?
|
| Mice | 47 | 2026 | 11137 | 1.580 |
Why?
|
| Animals | 60 | 2026 | 21379 | 1.440 |
Why?
|
| Genetic Vectors | 4 | 2025 | 925 | 1.310 |
Why?
|
| Cell Differentiation | 18 | 2026 | 1386 | 1.300 |
Why?
|
| Wnt Signaling Pathway | 3 | 2024 | 86 | 1.230 |
Why?
|
| MAP Kinase Kinase Kinases | 11 | 2020 | 83 | 1.200 |
Why?
|
| Osteogenesis Imperfecta | 2 | 2026 | 5 | 1.130 |
Why?
|
| Activin Receptors, Type I | 4 | 2023 | 15 | 1.100 |
Why?
|
| Interleukin-1 | 3 | 2025 | 154 | 0.990 |
Why?
|
| Disease Models, Animal | 11 | 2026 | 2305 | 0.990 |
Why?
|
| Stem Cells | 4 | 2022 | 276 | 0.970 |
Why?
|
| STAT2 Transcription Factor | 1 | 2026 | 9 | 0.970 |
Why?
|
| DNA-Binding Proteins | 6 | 2023 | 1225 | 0.950 |
Why?
|
| beta Catenin | 4 | 2023 | 99 | 0.910 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 1 | 2025 | 29 | 0.910 |
Why?
|
| Mitochondria | 2 | 2026 | 410 | 0.880 |
Why?
|
| Alveolar Bone Loss | 1 | 2024 | 4 | 0.850 |
Why?
|
| NF-kappa B | 10 | 2016 | 435 | 0.800 |
Why?
|
| Oxidative Phosphorylation | 1 | 2022 | 43 | 0.740 |
Why?
|
| MicroRNAs | 3 | 2025 | 712 | 0.740 |
Why?
|
| Osteocytes | 1 | 2022 | 14 | 0.720 |
Why?
|
| Sirtuin 1 | 1 | 2022 | 27 | 0.710 |
Why?
|
| Bone Remodeling | 2 | 2021 | 25 | 0.690 |
Why?
|
| Humans | 54 | 2026 | 65452 | 0.690 |
Why?
|
| Inflammation | 2 | 2025 | 1193 | 0.680 |
Why?
|
| MAP Kinase Signaling System | 5 | 2020 | 235 | 0.680 |
Why?
|
| Core Binding Factor Alpha 1 Subunit | 2 | 2020 | 142 | 0.680 |
Why?
|
| Fractures, Bone | 1 | 2022 | 138 | 0.680 |
Why?
|
| TNF Receptor-Associated Factor 6 | 6 | 2025 | 26 | 0.670 |
Why?
|
| Drug Delivery Systems | 1 | 2024 | 333 | 0.650 |
Why?
|
| MAP Kinase Kinase Kinase 2 | 2 | 2020 | 2 | 0.640 |
Why?
|
| Ubiquitination | 8 | 2019 | 120 | 0.640 |
Why?
|
| Mice, Inbred C57BL | 17 | 2025 | 3488 | 0.630 |
Why?
|
| Homeostasis | 2 | 2020 | 380 | 0.610 |
Why?
|
| Mice, Knockout | 14 | 2026 | 2162 | 0.590 |
Why?
|
| Phosphorylation | 10 | 2022 | 962 | 0.560 |
Why?
|
| Mice, Transgenic | 10 | 2022 | 1290 | 0.550 |
Why?
|
| Gene Silencing | 2 | 2025 | 433 | 0.530 |
Why?
|
| Cartilage | 3 | 2019 | 35 | 0.520 |
Why?
|
| Toll-Like Receptor 4 | 6 | 2016 | 350 | 0.500 |
Why?
|
| Bone Morphogenetic Protein 7 | 2 | 2014 | 16 | 0.460 |
Why?
|
| Tissue Engineering | 2 | 2026 | 148 | 0.460 |
Why?
|
| Bone Regeneration | 1 | 2015 | 14 | 0.460 |
Why?
|
| Endosomes | 3 | 2025 | 180 | 0.460 |
Why?
|
| Mitogen-Activated Protein Kinase 14 | 2 | 2014 | 10 | 0.460 |
Why?
|
| Gene Expression Regulation, Developmental | 4 | 2014 | 663 | 0.460 |
Why?
|
| Bone Morphogenetic Protein 2 | 2 | 2014 | 50 | 0.460 |
Why?
|
| Protein Stability | 3 | 2026 | 95 | 0.450 |
Why?
|
| Odontogenesis | 1 | 2014 | 2 | 0.440 |
Why?
|
| Ameloblasts | 1 | 2014 | 3 | 0.440 |
Why?
|
| Incisor | 1 | 2014 | 7 | 0.440 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 5 | 2025 | 345 | 0.440 |
Why?
|
| Dental Enamel | 1 | 2014 | 13 | 0.440 |
Why?
|
| Tissue Scaffolds | 1 | 2015 | 91 | 0.420 |
Why?
|
| Organoids | 2 | 2026 | 41 | 0.390 |
Why?
|
| HEK293 Cells | 10 | 2024 | 617 | 0.390 |
Why?
|
| Gene Transfer Techniques | 3 | 2024 | 325 | 0.390 |
Why?
|
| CREB-Binding Protein | 2 | 2011 | 15 | 0.370 |
Why?
|
| Rubinstein-Taybi Syndrome | 1 | 2011 | 1 | 0.360 |
Why?
|
| Fetal Therapies | 1 | 2011 | 2 | 0.360 |
Why?
|
| T-Lymphocytes | 5 | 2019 | 1008 | 0.340 |
Why?
|
| Cleidocranial Dysplasia | 2 | 2020 | 8 | 0.310 |
Why?
|
| Bone Morphogenetic Protein Receptors | 1 | 2009 | 14 | 0.300 |
Why?
|
| Oxidative Stress | 2 | 2022 | 322 | 0.290 |
Why?
|
| Apoptosis | 4 | 2013 | 1098 | 0.290 |
Why?
|
| Gene Deletion | 2 | 2020 | 312 | 0.280 |
Why?
|
| Endothelial Cells | 2 | 2023 | 213 | 0.280 |
Why?
|
| ErbB Receptors | 2 | 2025 | 128 | 0.270 |
Why?
|
| Bone Diseases, Metabolic | 2 | 2017 | 20 | 0.270 |
Why?
|
| Lysosomes | 2 | 2025 | 174 | 0.260 |
Why?
|
| Molecular Sequence Data | 6 | 2015 | 1979 | 0.250 |
Why?
|
| Cell Line | 10 | 2014 | 2024 | 0.250 |
Why?
|
| Toll-Like Receptors | 2 | 2025 | 434 | 0.250 |
Why?
|
| Reactive Oxygen Species | 2 | 2026 | 237 | 0.250 |
Why?
|
| Mutation | 5 | 2022 | 2665 | 0.250 |
Why?
|
| Chondrocytes | 2 | 2021 | 45 | 0.240 |
Why?
|
| Immunohistochemistry | 3 | 2019 | 897 | 0.240 |
Why?
|
| Collagen Type I | 1 | 2026 | 44 | 0.240 |
Why?
|
| Pyrroline Carboxylate Reductases | 1 | 2025 | 1 | 0.240 |
Why?
|
| Thiolester Hydrolases | 1 | 2025 | 10 | 0.230 |
Why?
|
| Ubiquitin-Protein Ligases | 3 | 2019 | 226 | 0.230 |
Why?
|
| Myostatin | 1 | 2025 | 20 | 0.230 |
Why?
|
| Rare Diseases | 1 | 2026 | 45 | 0.230 |
Why?
|
| Embryonic Development | 1 | 2006 | 142 | 0.220 |
Why?
|
| Stem Cell Transplantation | 1 | 2025 | 79 | 0.210 |
Why?
|
| Carcinogenesis | 1 | 2025 | 135 | 0.210 |
Why?
|
| Aptamers, Nucleotide | 1 | 2024 | 27 | 0.210 |
Why?
|
| Cellular Senescence | 1 | 2025 | 121 | 0.210 |
Why?
|
| Lead | 1 | 2024 | 46 | 0.210 |
Why?
|
| Models, Biological | 4 | 2026 | 1192 | 0.200 |
Why?
|
| Blotting, Western | 4 | 2019 | 611 | 0.200 |
Why?
|
| Myocardium | 1 | 2025 | 302 | 0.200 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2025 | 185 | 0.200 |
Why?
|
| Nerve Tissue Proteins | 3 | 2021 | 428 | 0.200 |
Why?
|
| Volatile Organic Compounds | 1 | 2023 | 22 | 0.200 |
Why?
|
| Activins | 1 | 2023 | 55 | 0.200 |
Why?
|
| Bone Marrow Cells | 4 | 2018 | 237 | 0.200 |
Why?
|
| Serogroup | 2 | 2021 | 35 | 0.190 |
Why?
|
| Colorectal Neoplasms | 1 | 2025 | 289 | 0.190 |
Why?
|
| Wearable Electronic Devices | 1 | 2023 | 77 | 0.180 |
Why?
|
| Female | 11 | 2025 | 34188 | 0.180 |
Why?
|
| RNA, Small Interfering | 2 | 2025 | 982 | 0.180 |
Why?
|
| Carrier Proteins | 2 | 2006 | 718 | 0.180 |
Why?
|
| Mice, Inbred BALB C | 3 | 2019 | 868 | 0.180 |
Why?
|
| Adenoviridae | 1 | 2022 | 130 | 0.180 |
Why?
|
| Cell Proliferation | 4 | 2025 | 1039 | 0.180 |
Why?
|
| Cells, Cultured | 7 | 2021 | 2188 | 0.180 |
Why?
|
| Membrane Proteins | 4 | 2023 | 924 | 0.180 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2022 | 132 | 0.170 |
Why?
|
| Patched-1 Receptor | 1 | 2021 | 13 | 0.170 |
Why?
|
| Immunoprecipitation | 2 | 2019 | 128 | 0.170 |
Why?
|
| Antifungal Agents | 1 | 2002 | 125 | 0.170 |
Why?
|
| Cancellous Bone | 1 | 2021 | 4 | 0.170 |
Why?
|
| Amino Acid Sequence | 5 | 2013 | 1588 | 0.170 |
Why?
|
| Mitogen-Activated Protein Kinase 8 | 2 | 2020 | 86 | 0.170 |
Why?
|
| Pyridazines | 1 | 2020 | 10 | 0.160 |
Why?
|
| Heart Transplantation | 1 | 2002 | 180 | 0.160 |
Why?
|
| RANK Ligand | 3 | 2015 | 23 | 0.160 |
Why?
|
| Receptors, Antigen, T-Cell | 2 | 2017 | 281 | 0.160 |
Why?
|
| Calcification, Physiologic | 1 | 2020 | 20 | 0.160 |
Why?
|
| Hedgehog Proteins | 1 | 2021 | 116 | 0.160 |
Why?
|
| Cartilage, Articular | 1 | 2021 | 79 | 0.160 |
Why?
|
| Ubiquitin-Specific Peptidase 7 | 1 | 2020 | 3 | 0.160 |
Why?
|
| Neurofibromatosis 1 | 1 | 2020 | 30 | 0.160 |
Why?
|
| Imidazoles | 1 | 2020 | 82 | 0.160 |
Why?
|
| Haploinsufficiency | 1 | 2020 | 20 | 0.160 |
Why?
|
| Immunosuppressive Agents | 1 | 2002 | 381 | 0.160 |
Why?
|
| Casein Kinase II | 1 | 2020 | 16 | 0.160 |
Why?
|
| Muscle, Skeletal | 1 | 2025 | 787 | 0.160 |
Why?
|
| Hindlimb | 1 | 2020 | 54 | 0.160 |
Why?
|
| Cilia | 1 | 2021 | 156 | 0.150 |
Why?
|
| Cell Communication | 1 | 2020 | 133 | 0.150 |
Why?
|
| Beclin-1 | 1 | 2019 | 22 | 0.150 |
Why?
|
| Transduction, Genetic | 1 | 2021 | 242 | 0.150 |
Why?
|
| Gene Editing | 1 | 2024 | 331 | 0.150 |
Why?
|
| Cell Line, Tumor | 6 | 2025 | 1567 | 0.150 |
Why?
|
| Osteoarthritis | 1 | 2021 | 146 | 0.150 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2015 | 542 | 0.150 |
Why?
|
| NF-KappaB Inhibitor alpha | 2 | 2016 | 25 | 0.150 |
Why?
|
| Mice, Mutant Strains | 3 | 2020 | 301 | 0.140 |
Why?
|
| Periosteum | 1 | 2018 | 6 | 0.140 |
Why?
|
| Immunoblotting | 2 | 2017 | 202 | 0.140 |
Why?
|
| Lung Neoplasms | 1 | 2025 | 708 | 0.140 |
Why?
|
| Disease Susceptibility | 1 | 2019 | 169 | 0.140 |
Why?
|
| Endothelium | 1 | 2018 | 21 | 0.140 |
Why?
|
| Capsid | 1 | 2019 | 104 | 0.140 |
Why?
|
| Caspase 3 | 2 | 2013 | 108 | 0.140 |
Why?
|
| Male | 9 | 2025 | 31177 | 0.140 |
Why?
|
| Diphosphonates | 1 | 2017 | 33 | 0.130 |
Why?
|
| In Situ Hybridization | 2 | 2015 | 213 | 0.130 |
Why?
|
| Thymocytes | 1 | 2017 | 23 | 0.130 |
Why?
|
| Jurkat Cells | 4 | 2019 | 109 | 0.130 |
Why?
|
| Caenorhabditis elegans | 1 | 2024 | 707 | 0.130 |
Why?
|
| Autophagy | 1 | 2019 | 237 | 0.130 |
Why?
|
| Bone Morphogenetic Proteins | 2 | 2010 | 64 | 0.130 |
Why?
|
| Protein Binding | 7 | 2016 | 1632 | 0.120 |
Why?
|
| Hematopoiesis | 1 | 2016 | 127 | 0.120 |
Why?
|
| DNA Primers | 2 | 2015 | 301 | 0.120 |
Why?
|
| Transcription Factor RelA | 2 | 2014 | 51 | 0.120 |
Why?
|
| Skull | 4 | 2020 | 52 | 0.120 |
Why?
|
| Peptide Hydrolases | 1 | 2016 | 79 | 0.120 |
Why?
|
| Lymphocyte Activation | 3 | 2010 | 753 | 0.120 |
Why?
|
| Cell Division | 3 | 2008 | 450 | 0.120 |
Why?
|
| Capillary Action | 1 | 2015 | 1 | 0.120 |
Why?
|
| Organ Size | 1 | 2016 | 173 | 0.120 |
Why?
|
| Valosin Containing Protein | 1 | 2015 | 5 | 0.110 |
Why?
|
| I-kappa B Proteins | 1 | 2015 | 37 | 0.110 |
Why?
|
| Bone Marrow Transplantation | 1 | 2015 | 140 | 0.110 |
Why?
|
| Luciferases | 1 | 2015 | 107 | 0.110 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 2 | 2012 | 45 | 0.110 |
Why?
|
| Stromal Cells | 1 | 2015 | 78 | 0.110 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2015 | 233 | 0.110 |
Why?
|
| Amelogenin | 1 | 2014 | 2 | 0.110 |
Why?
|
| MAP Kinase Kinase 6 | 1 | 2014 | 12 | 0.110 |
Why?
|
| p21-Activated Kinases | 1 | 2014 | 6 | 0.110 |
Why?
|
| MAP Kinase Kinase 3 | 1 | 2014 | 27 | 0.110 |
Why?
|
| NF-kappa B p50 Subunit | 1 | 2014 | 27 | 0.110 |
Why?
|
| Tissue Culture Techniques | 1 | 2014 | 33 | 0.110 |
Why?
|
| Gene Expression | 4 | 2021 | 854 | 0.110 |
Why?
|
| Integrin beta4 | 1 | 2014 | 35 | 0.110 |
Why?
|
| Base Sequence | 2 | 2015 | 1331 | 0.100 |
Why?
|
| Recombinant Proteins | 2 | 2018 | 706 | 0.100 |
Why?
|
| Wound Healing | 1 | 2015 | 193 | 0.100 |
Why?
|
| Sequence Analysis, RNA | 1 | 2015 | 181 | 0.100 |
Why?
|
| Adult | 2 | 2022 | 17457 | 0.100 |
Why?
|
| RNA, Messenger | 1 | 2020 | 1575 | 0.100 |
Why?
|
| Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2013 | 22 | 0.100 |
Why?
|
| NFATC Transcription Factors | 1 | 2013 | 20 | 0.100 |
Why?
|
| X-Ray Microtomography | 2 | 2026 | 27 | 0.100 |
Why?
|
| Cell Movement | 2 | 2025 | 482 | 0.100 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2013 | 36 | 0.100 |
Why?
|
| Enzyme Activation | 4 | 2020 | 391 | 0.100 |
Why?
|
| Adenosine Triphosphatases | 1 | 2015 | 256 | 0.100 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2013 | 46 | 0.100 |
Why?
|
| Biomarkers | 1 | 2019 | 1483 | 0.100 |
Why?
|
| Calcineurin | 1 | 2013 | 48 | 0.100 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2013 | 219 | 0.100 |
Why?
|
| Amino Acid Motifs | 1 | 2013 | 156 | 0.100 |
Why?
|
| Zinc | 1 | 2013 | 95 | 0.090 |
Why?
|
| Cell Cycle Proteins | 1 | 2015 | 403 | 0.090 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2025 | 586 | 0.090 |
Why?
|
| Phenotype | 3 | 2020 | 1233 | 0.090 |
Why?
|
| Proteins | 2 | 2011 | 764 | 0.090 |
Why?
|
| Hyperparathyroidism, Secondary | 1 | 2012 | 6 | 0.090 |
Why?
|
| Neuroprotective Agents | 1 | 2013 | 78 | 0.090 |
Why?
|
| Hand Deformities, Congenital | 1 | 2011 | 4 | 0.090 |
Why?
|
| Protein Structure, Tertiary | 1 | 2013 | 672 | 0.090 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2011 | 10 | 0.090 |
Why?
|
| Dwarfism | 1 | 2011 | 16 | 0.090 |
Why?
|
| Uterus | 1 | 2011 | 41 | 0.090 |
Why?
|
| Receptors, Immunologic | 2 | 2018 | 179 | 0.090 |
Why?
|
| Lipopolysaccharides | 4 | 2016 | 625 | 0.090 |
Why?
|
| Cytoplasm | 1 | 2013 | 283 | 0.090 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2011 | 83 | 0.090 |
Why?
|
| Monocytes | 1 | 2013 | 361 | 0.090 |
Why?
|
| I-kappa B Kinase | 3 | 2005 | 50 | 0.080 |
Why?
|
| Disease Progression | 2 | 2025 | 1221 | 0.080 |
Why?
|
| Goosecoid Protein | 1 | 2010 | 4 | 0.080 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 3 | 1 | 2010 | 18 | 0.080 |
Why?
|
| T-Box Domain Proteins | 1 | 2010 | 38 | 0.080 |
Why?
|
| Craniofacial Abnormalities | 1 | 2010 | 23 | 0.080 |
Why?
|
| Neurodegenerative Diseases | 1 | 2013 | 152 | 0.080 |
Why?
|
| Th17 Cells | 1 | 2010 | 63 | 0.080 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2010 | 59 | 0.080 |
Why?
|
| Heart Defects, Congenital | 1 | 2011 | 101 | 0.080 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 1 | 2010 | 82 | 0.080 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2010 | 58 | 0.080 |
Why?
|
| fas Receptor | 1 | 2010 | 56 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 2 | 2017 | 104 | 0.080 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2010 | 363 | 0.080 |
Why?
|
| Embryo, Mammalian | 2 | 2010 | 158 | 0.080 |
Why?
|
| Femur | 2 | 2020 | 56 | 0.070 |
Why?
|
| Group VI Phospholipases A2 | 1 | 2008 | 1 | 0.070 |
Why?
|
| Peroxiredoxin VI | 1 | 2008 | 2 | 0.070 |
Why?
|
| Oxidants | 1 | 2008 | 18 | 0.070 |
Why?
|
| G2 Phase | 1 | 2008 | 23 | 0.070 |
Why?
|
| Gene Expression Regulation | 4 | 2018 | 1631 | 0.070 |
Why?
|
| Down-Regulation | 2 | 2008 | 324 | 0.070 |
Why?
|
| Hydrogen Peroxide | 1 | 2008 | 83 | 0.070 |
Why?
|
| COS Cells | 2 | 2005 | 180 | 0.070 |
Why?
|
| Fracture Healing | 2 | 2018 | 26 | 0.070 |
Why?
|
| HeLa Cells | 3 | 2008 | 541 | 0.070 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2008 | 129 | 0.070 |
Why?
|
| Insulin | 1 | 2011 | 695 | 0.070 |
Why?
|
| Transfection | 2 | 2006 | 700 | 0.060 |
Why?
|
| Neurons | 1 | 2013 | 934 | 0.060 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2008 | 604 | 0.060 |
Why?
|
| Horseradish Peroxidase | 1 | 2006 | 14 | 0.060 |
Why?
|
| Green Fluorescent Proteins | 2 | 2021 | 372 | 0.060 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2006 | 30 | 0.060 |
Why?
|
| HT29 Cells | 1 | 2025 | 28 | 0.060 |
Why?
|
| NIH 3T3 Cells | 1 | 2006 | 99 | 0.060 |
Why?
|
| Microscopy, Fluorescence | 2 | 2017 | 401 | 0.060 |
Why?
|
| TNF Receptor-Associated Factor 2 | 1 | 2005 | 11 | 0.060 |
Why?
|
| Cell Line, Transformed | 1 | 2005 | 97 | 0.060 |
Why?
|
| Transcription Factor AP-1 | 1 | 2005 | 46 | 0.060 |
Why?
|
| Interleukin-1 Receptor-Associated Kinases | 1 | 2005 | 34 | 0.060 |
Why?
|
| Antigens, Differentiation | 1 | 2005 | 144 | 0.060 |
Why?
|
| Cytokines | 3 | 2016 | 951 | 0.060 |
Why?
|
| Mice, Nude | 1 | 2025 | 286 | 0.060 |
Why?
|
| GTPase-Activating Proteins | 1 | 2005 | 69 | 0.060 |
Why?
|
| Endocytosis | 1 | 2006 | 152 | 0.060 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2006 | 179 | 0.060 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2005 | 141 | 0.060 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2005 | 203 | 0.050 |
Why?
|
| Caspases | 2 | 2005 | 176 | 0.050 |
Why?
|
| Gene Knockdown Techniques | 2 | 2016 | 204 | 0.050 |
Why?
|
| Isoenzymes | 1 | 2005 | 130 | 0.050 |
Why?
|
| Protein Kinases | 1 | 2005 | 153 | 0.050 |
Why?
|
| Protein Kinase C | 1 | 2005 | 102 | 0.050 |
Why?
|
| Rats | 2 | 2013 | 1996 | 0.050 |
Why?
|
| Pregnancy | 1 | 2011 | 2390 | 0.050 |
Why?
|
| Ubiquitin | 1 | 2004 | 104 | 0.050 |
Why?
|
| Embryonic and Fetal Development | 1 | 2003 | 46 | 0.050 |
Why?
|
| Bone Density | 1 | 2024 | 142 | 0.050 |
Why?
|
| Aged | 1 | 2020 | 15048 | 0.050 |
Why?
|
| Heart | 1 | 2025 | 298 | 0.050 |
Why?
|
| Chlorobenzenes | 1 | 2023 | 30 | 0.050 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2014 | 297 | 0.050 |
Why?
|
| Biosensing Techniques | 1 | 2024 | 126 | 0.050 |
Why?
|
| Receptor-CD3 Complex, Antigen, T-Cell | 1 | 2002 | 3 | 0.050 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2002 | 31 | 0.050 |
Why?
|
| Middle Aged | 1 | 2020 | 18383 | 0.050 |
Why?
|
| Rats, Inbred Lew | 1 | 2002 | 106 | 0.050 |
Why?
|
| Furans | 1 | 2002 | 28 | 0.050 |
Why?
|
| Caspase 9 | 1 | 2002 | 21 | 0.050 |
Why?
|
| Cyclosporine | 1 | 2002 | 77 | 0.050 |
Why?
|
| Tyrosine | 1 | 2002 | 93 | 0.050 |
Why?
|
| Rats, Wistar | 1 | 2002 | 184 | 0.040 |
Why?
|
| Molecular Structure | 1 | 2002 | 315 | 0.040 |
Why?
|
| Neurofibromin 1 | 1 | 2020 | 14 | 0.040 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2020 | 38 | 0.040 |
Why?
|
| Gene Expression Profiling | 2 | 2014 | 795 | 0.040 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 2011 | 149 | 0.040 |
Why?
|
| Feasibility Studies | 1 | 2022 | 589 | 0.040 |
Why?
|
| Lipids | 1 | 2002 | 328 | 0.040 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2020 | 198 | 0.040 |
Why?
|
| Cathepsin K | 1 | 2018 | 8 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2023 | 1710 | 0.040 |
Why?
|
| Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2018 | 16 | 0.030 |
Why?
|
| Sialoglycoproteins | 1 | 2018 | 20 | 0.030 |
Why?
|
| Ovariectomy | 1 | 2018 | 104 | 0.030 |
Why?
|
| Hexosamines | 1 | 2017 | 4 | 0.030 |
Why?
|
| Osteoporosis, Postmenopausal | 1 | 2018 | 47 | 0.030 |
Why?
|
| Bacterial Infections | 1 | 2019 | 150 | 0.030 |
Why?
|
| Azides | 1 | 2017 | 22 | 0.030 |
Why?
|
| Drosophila Proteins | 1 | 2003 | 757 | 0.030 |
Why?
|
| Durapatite | 1 | 2017 | 27 | 0.030 |
Why?
|
| Insulin-Like Growth Factor II | 1 | 2017 | 23 | 0.030 |
Why?
|
| Neovascularization, Physiologic | 1 | 2018 | 113 | 0.030 |
Why?
|
| Cell- and Tissue-Based Therapy | 1 | 2017 | 42 | 0.030 |
Why?
|
| Bcl-2-Like Protein 11 | 1 | 2017 | 20 | 0.030 |
Why?
|
| RNA Interference | 2 | 2014 | 644 | 0.030 |
Why?
|
| Pancytopenia | 1 | 2016 | 7 | 0.030 |
Why?
|
| Stem Cell Niche | 1 | 2016 | 18 | 0.030 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2017 | 139 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2017 | 211 | 0.030 |
Why?
|
| Cell Survival | 1 | 2017 | 587 | 0.030 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2017 | 234 | 0.030 |
Why?
|
| Protein Interaction Maps | 1 | 2015 | 35 | 0.030 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2017 | 268 | 0.030 |
Why?
|
| Inflammation Mediators | 1 | 2016 | 179 | 0.030 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2016 | 299 | 0.030 |
Why?
|
| Ribosomal Protein S6 Kinases, 90-kDa | 1 | 2013 | 7 | 0.030 |
Why?
|
| Mice, 129 Strain | 1 | 2013 | 41 | 0.030 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2016 | 353 | 0.030 |
Why?
|
| Multiprotein Complexes | 1 | 2014 | 156 | 0.020 |
Why?
|
| Cytoprotection | 1 | 2013 | 18 | 0.020 |
Why?
|
| Transcriptional Activation | 1 | 2013 | 196 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2013 | 241 | 0.020 |
Why?
|
| Sepsis | 1 | 2016 | 302 | 0.020 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2012 | 38 | 0.020 |
Why?
|
| Coculture Techniques | 1 | 2012 | 104 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2013 | 213 | 0.020 |
Why?
|
| Genitalia, Male | 1 | 2011 | 11 | 0.020 |
Why?
|
| cdc42 GTP-Binding Protein | 1 | 2011 | 23 | 0.020 |
Why?
|
| Face | 1 | 2011 | 36 | 0.020 |
Why?
|
| Gene Knock-In Techniques | 1 | 2011 | 48 | 0.020 |
Why?
|
| Cell Death | 1 | 2013 | 289 | 0.020 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2011 | 62 | 0.020 |
Why?
|
| SOXD Transcription Factors | 1 | 2010 | 6 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2013 | 663 | 0.020 |
Why?
|
| Cell Nucleus | 1 | 2014 | 631 | 0.020 |
Why?
|
| Tarsal Joints | 1 | 2010 | 4 | 0.020 |
Why?
|
| Bone Diseases, Developmental | 1 | 2010 | 7 | 0.020 |
Why?
|
| Calcium | 1 | 2013 | 584 | 0.020 |
Why?
|
| Forelimb | 1 | 2010 | 11 | 0.020 |
Why?
|
| Smad Proteins | 1 | 2010 | 23 | 0.020 |
Why?
|
| Joints | 1 | 2010 | 33 | 0.020 |
Why?
|
| Protein Engineering | 1 | 2010 | 85 | 0.020 |
Why?
|
| Cell Lineage | 1 | 2010 | 282 | 0.020 |
Why?
|
| Gene Regulatory Networks | 1 | 2010 | 160 | 0.020 |
Why?
|
| Transforming Growth Factor beta | 1 | 2010 | 181 | 0.020 |
Why?
|
| Cyclin B1 | 1 | 2008 | 9 | 0.020 |
Why?
|
| Cyclin B | 1 | 2008 | 17 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2010 | 501 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2010 | 344 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2008 | 238 | 0.020 |
Why?
|
| Macrophages | 1 | 2013 | 1038 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 2008 | 328 | 0.020 |
Why?
|
| Mutation, Missense | 1 | 2008 | 190 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2008 | 376 | 0.020 |
Why?
|
| Protein Subunits | 1 | 2008 | 169 | 0.020 |
Why?
|
| Antibodies | 1 | 2008 | 187 | 0.020 |
Why?
|
| Catalytic Domain | 1 | 2008 | 198 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2008 | 857 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2008 | 314 | 0.020 |
Why?
|
| Aging | 1 | 2012 | 774 | 0.010 |
Why?
|
| Mucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 Protein | 1 | 2005 | 1 | 0.010 |
Why?
|
| B-Cell CLL-Lymphoma 10 Protein | 1 | 2005 | 2 | 0.010 |
Why?
|
| 3-Phosphoinositide-Dependent Protein Kinases | 1 | 2005 | 5 | 0.010 |
Why?
|
| Guanylate Cyclase | 1 | 2005 | 11 | 0.010 |
Why?
|
| Lymphoma, B-Cell, Marginal Zone | 1 | 2005 | 8 | 0.010 |
Why?
|
| Protein Kinase C-theta | 1 | 2005 | 16 | 0.010 |
Why?
|
| Membrane Microdomains | 1 | 2005 | 51 | 0.010 |
Why?
|
| CARD Signaling Adaptor Proteins | 1 | 2005 | 66 | 0.010 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2005 | 178 | 0.010 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2005 | 152 | 0.010 |
Why?
|
| Smad1 Protein | 1 | 2003 | 5 | 0.010 |
Why?
|
| Catalysis | 1 | 2004 | 164 | 0.010 |
Why?
|
| Genes, Lethal | 1 | 2003 | 57 | 0.010 |
Why?
|
| Neoplasm Proteins | 1 | 2005 | 285 | 0.010 |
Why?
|